334 related articles for article (PubMed ID: 28954765)
1. New insights in lymphangioleiomyomatosis and pulmonary Langerhans cell histiocytosis.
Torre O; Elia D; Caminati A; Harari S
Eur Respir Rev; 2017 Sep; 26(145):. PubMed ID: 28954765
[TBL] [Abstract][Full Text] [Related]
2. How I manage pulmonary Langerhans cell histiocytosis.
Lorillon G; Tazi A
Eur Respir Rev; 2017 Sep; 26(145):. PubMed ID: 28877978
[TBL] [Abstract][Full Text] [Related]
3. Vemurafenib Use in an Infant for High-Risk Langerhans Cell Histiocytosis.
Héritier S; Jehanne M; Leverger G; Emile JF; Alvarez JC; Haroche J; Donadieu J
JAMA Oncol; 2015 Sep; 1(6):836-8. PubMed ID: 26180941
[No Abstract] [Full Text] [Related]
4. Lymphangioleiomyomatosis: what do we know and what are we looking for?
Harari S; Torre O; Moss J
Eur Respir Rev; 2011 Mar; 20(119):34-44. PubMed ID: 21357890
[TBL] [Abstract][Full Text] [Related]
5. Chest Computed Tomographic Image Screening for Cystic Lung Diseases in Patients with Spontaneous Pneumothorax Is Cost Effective.
Gupta N; Langenderfer D; McCormack FX; Schauer DP; Eckman MH
Ann Am Thorac Soc; 2017 Jan; 14(1):17-25. PubMed ID: 27737563
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary Langerhans Cell Histiocytosis and Lymphangioleiomyomatosis Have Circulating Cells With Loss of Heterozygosity of the TSC2 Gene.
Elia D; Torre O; Vasco C; Geginat J; Abrignani S; Bulgheroni E; Carelli E; Cassandro R; Pacheco-Rodriguez G; Steagall WK; Moss J; Harari S
Chest; 2022 Aug; 162(2):385-393. PubMed ID: 35231481
[TBL] [Abstract][Full Text] [Related]
7. Clinical challenges in a patient with two BRAF V600E-mutated diseases.
Willenbacher E; Willenbacher W; Loeffler-Ragg J
Thorax; 2019 Jun; 74(6):620-622. PubMed ID: 30661020
[No Abstract] [Full Text] [Related]
8. Progress towards molecular-based management of childhood Langerhans cell histiocytosis.
Héritier S; Emile JF; Hélias-Rodzewicz Z; Donadieu J
Arch Pediatr; 2019 Jul; 26(5):301-307. PubMed ID: 31281037
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary Langerhans Cell Histiocytosis: An Update From the Pathologists' Perspective.
Roden AC; Yi ES
Arch Pathol Lab Med; 2016 Mar; 140(3):230-40. PubMed ID: 26927717
[TBL] [Abstract][Full Text] [Related]
10. [Rare cystic lung diseases: lymphangioleiomyomatosis, pulmonary Langerhans' cell histiocytosis and lymphocytic interstitial pneumonia].
Prasse A; Kayser G
Dtsch Med Wochenschr; 2010 Mar; 135(10):461-5. PubMed ID: 20198543
[No Abstract] [Full Text] [Related]
11. The diagnosis of cystic lung diseases: a role for bronchoalveolar lavage and transbronchial biopsy?
Torre O; Harari S
Respir Med; 2010 Jul; 104 Suppl 1():S81-5. PubMed ID: 20430602
[TBL] [Abstract][Full Text] [Related]
12. Systemic Histiocytosis (Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Destombes-Rosai-Dorfman Disease): from Oncogenic Mutations to Inflammatory Disorders.
Papo M; Cohen-Aubart F; Trefond L; Bauvois A; Amoura Z; Emile JF; Haroche J
Curr Oncol Rep; 2019 May; 21(7):62. PubMed ID: 31115724
[TBL] [Abstract][Full Text] [Related]
13. Lymphangioleiomyomatosis: Current understanding and potential treatments.
Moir LM
Pharmacol Ther; 2016 Feb; 158():114-24. PubMed ID: 26713679
[TBL] [Abstract][Full Text] [Related]
14. Bronchoalveolar lavage for the diagnosis of Pulmonary Langerhans cell histiocytosis.
Lommatzsch M; Bratke K; Stoll P; Mülleneisen N; Prall F; Bier A; Virchow JC
Respir Med; 2016 Oct; 119():168-174. PubMed ID: 27692140
[TBL] [Abstract][Full Text] [Related]
15. mTOR treatment in lymphangioleiomyomatosis: the role of everolimus.
Yates DH
Expert Rev Respir Med; 2016; 10(3):249-60. PubMed ID: 26847859
[TBL] [Abstract][Full Text] [Related]
16. Lymphangioleiomyomatosis (LAM): molecular insights lead to targeted therapies.
Glasgow CG; Steagall WK; Taveira-Dasilva A; Pacheco-Rodriguez G; Cai X; El-Chemaly S; Moses M; Darling T; Moss J
Respir Med; 2010 Jul; 104 Suppl 1(Suppl 1):S45-58. PubMed ID: 20630348
[TBL] [Abstract][Full Text] [Related]
17. Cystic lung disease: achieving a radiologic diagnosis.
Trotman-Dickenson B
Eur J Radiol; 2014 Jan; 83(1):39-46. PubMed ID: 24342705
[TBL] [Abstract][Full Text] [Related]
18. Cystic interstitial lung diseases: recognizing the common and uncommon entities.
Jawad H; Walker CM; Wu CC; Chung JH
Curr Probl Diagn Radiol; 2014; 43(3):115-27. PubMed ID: 24791615
[TBL] [Abstract][Full Text] [Related]
19. A different cause for respiratory disorder in children: cases with pulmonary Langerhans cell histiocytosis.
Asilsoy S; Yazici N; Demir S; Erbay A; Koçer E; Sarıalioğlu F
Clin Respir J; 2017 Mar; 11(2):193-199. PubMed ID: 26083968
[TBL] [Abstract][Full Text] [Related]
20. [Pathomorphological features of pulmonary Langerhans cell histiocytosis].
Cherniaev AL; Voĭtkovskaia KS; Tarabrin EA; Avdeev SN; Karchevskaia NA; Samsonova MV
Arkh Patol; 2014; 76(6):56-60. PubMed ID: 25842927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
